Group A/C meningococcal conjugate vaccine (CanSino biologics)

A群C群脑膜炎球菌结合疫苗（康希诺生物）

Report date: 2024/04/12 16:00:42

Base Information

Drug NameGroup A/C meningococcal conjugate vaccine (CanSino biologics)

Drug Alias Name美奈喜MCV-2

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningitisMeningitis, Meningococcal

Global Approved IndicationsMeningitis

Approved Indications in ChinaMeningitis

Original Approved Country/TerritoryMainland China

Original Approved Date2021/06/22

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesTianjin Cansino Biotechnology Inc

China Registration ClassN/A

Develop Information

Active CompaniesTianjin Cansino Biotechnology Inc

Inactive CompaniesN/A

Active IndicationsMeningitis

Inactive IndicationsMeningitis, Meningococcal

Other Information

ATC CodeN/A